Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 17, 2019 (7 years ago)

Gatifloxacin Ophthalmic Solution 0.5%

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or missing package insert.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL bottle, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc. Princeton, NJ 08540, Product of India, NDC 61314-672-25.

Affected NDC 61314-0672-25

Compare with the code on your package — it is the most precise check available.

Drug: Gatifloxacin Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Gatifloxacin
NDC 61314-0672
5 mg/mL Solution/ Drops
Ophthalmic
Sandoz Inc Rx
Recalling firm
Sandoz Inc
NDC code
61314-672-25
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0163-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Gatifloxacin recalls

See all
Class II · Moderate risk

Pred Acetate / Gatifloxacin 1% / 0.5% Susp

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Ongoing Sterility / contamination Pharmacy Plus, Inc. dba Vital Care Compounder D-0051-2023
Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0326-2022
Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0091-2022

Other recalls by Sandoz Inc

All 2019 recalls
Class III · Low risk

Focalin XR

Labeling: Incorrect or Missing Lot and/or Exp Date

Ongoing Labeling / mix-up Sandoz Inc D-0608-2026